• Title of article

    The magnitude of extended-spectrum beta-lactamase- producing Enterobacteriaceae from clinical samples in Ethiopia: a systematic review and meta-analysis

  • Author/Authors

    Diriba, Kuma Department of Medical Laboratory Sciences - Health Science and Medical College - Dilla University, Dilla, Ethiopia , Awulachew, Ephrem Department of Medical Laboratory Sciences - Health Science and Medical College - Dilla University, Dilla, Ethiopia , Gemede, Aschelew Department of Medical Laboratory Sciences - Health Science and Medical College - Dilla University, Dilla, Ethiopia , Anja, Asrat Department of Medical Laboratory Sciences - Health Science and Medical College - Dilla University, Dilla, Ethiopia

  • Pages
    10
  • From page
    1
  • To page
    10
  • Abstract
    Background The rapid spread of resistance among extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is a serious problem around the world. It results in serious clinical complications in humans and has become a global threat. Therefore, this systematic review and meta-analysis was aimed to estimate the pooled prevalence of ESBL-producing Enterobacteriaceae in different clinical samples in Ethiopia. Methods A systematic search was conducted on PubMed, Web of Science, Embase, Google Scholar and the Cochrane Library. All identified observational studies reporting the prevalence of ESBL-producing Enterobacteriaceae from clinical samples in Ethiopia were included. Four authors independently extracted data and analysed using R software version 3.6.1 and STATA statistical software version 13. A random-effects model was computed to estimate the pooled prevalence of ESBL-producing Enterobacteriaceae in Ethiopia. Results Of 142 articles reviewed, 14 studies that fulfilled the inclusion criteria were included in the meta-analysis. The pooled prevalence of ESBL-producing Enterobacteriaceae in the different clinical specimens in Ethiopia was 49 % (95 % CI: 39, 60). Klebsiella pneumoniae was the leading ESBL-producing Enterobacteriaceae followed by Escherichia coli and Acinetobacter baumannii with a prevalence of 74, 67 and 60 %, respectively. ESBL-producing isolates showed a high rate of resistance to cefotaxime, ceftriaxone, ceftazidime, Amoxicillin clavulanic acid (AMC), ampicillin and aztreonam. The better options for the treatment of ESBL-producing Enterobacteriaceae are amikacin and Imipenem. Conclusion The magnitude of ESBL-producing Enterobacteriaceae in different clinical samples in Ethiopia is alarmingly high and represents a threat to human health. Hence, a coordinated effort needs to be implemented for the prevention and control of these Enterobacteriaceae .
  • Keywords
    extended-spectrum β-lactamase , β-lactam resistance , antibiotic resistance , Enterobacteriaceae , Klepsiella pneumonia , Escherichia coli , Ethiopia
  • Journal title
    Access Microbiology
  • Serial Year
    2021
  • Record number

    2617823